DF, or anyone for that matter,
I'm wondering what your thoughts are on how IHL will be valued on the Nasdaq when we list.
I'm not sure what is happening in the US in regards to the shroom/cannabis stocks, but they have all been falling the last year, and the m/caps have halved, from what they were. Have you or anyone got a handle on what is happening in this space.
Looks like IHL will be coming onstream to a downwards market in this space. I'm tempering my SP targets to approx $1-$1.20 as a peer valuation, at some time after listing.
I know good results mean m/cap $$ to these stocks and vice versa, so ultimately our SP will be judged on this, which if sleep apnea results are positive, then I believe a SP of >$2 beckons.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-10989
-
- There are more pages in this discussion • 8,907 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online